RGENIX to Present at Multiple Virtual Healthcare Investor Conferences in August
New York, NY – Aug 05, 2020 - RGENIX, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced today that it has been selected to present at multiple virtual healthcare investor conferences taking place during the month of August. These conferences include: LifeSci Partners Summer Symposium August 5, 2020